The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
Antonella Fattorusso(University of Perugia), Alberto Verrottı(University of Perugia), Elisabetta Mencaroni(University of Perugia), Giovanni Battista Dell’Isola(Vita-Salute San Raffaele University), Giuseppe Di Cara(University of Perugia), Sara Matricardi(Ospedali Riuniti di Ancona), Pasquale Striano(Great Ormond Street Hospital)
Cited by 260
Related Papers
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Autism Spectrum Disorders and the Gut Microbiota
|Nutrients|2019|479
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|249
Microbiota-gut brain axis involvement in neuropsychiatric disorders
|Expert Review of Neurotherapeutics|2019|177
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
|Epilepsia|2018|151